USCDI Export for the Public
| Classification Level Sort descending | Data Class | Data Class Description | Data Element | Data Element Description | Applicable Standards | Submitter Name | Submitter Organization | Submission Date |
|---|---|---|---|---|---|---|---|---|
| Draft USCDI V6 | Pharmacologic agents used in the diagnosis, cure, mitigation, treatment, or prevention of disease. |
Directions for administering or taking a medication. Usage note: May include route, quantity, timing/frequency, and special instructions (PRN, sliding scale, taper). Examples include but are not limited to prescription directions for taking a medication, and package instructions for over-the-counter medications. |
Shelly Spiro | Pharmacy HIT Collaborative | ||||
| Draft USCDI V6 | Data used to categorize individuals for identification, records matching, and other purposes. |
Occupation Industry |
Type of business that compensates for work or assigns work to an unpaid worker or volunteer. Examples include but are not limited to U.S. Army, cement manufacturing, and children and youth services. |
|
Nedra Garrett | CDC | ||
| Draft USCDI V6 | Data used to categorize individuals for identification, records matching, and other purposes. |
Occupation |
Type of work of a person. Examples include but are not limited to infantry, business analyst, and social worker. |
|
Nedra Garrett | CDC | ||
| Draft USCDI V6 | Pharmacologic agents used in the diagnosis, cure, mitigation, treatment, or prevention of disease. |
Statement of whether a medication has been consumed according to instructions. Examples include but are not limited to taking as directed, taking less than directed, and not taking. |
|
Shelly Spiro | Pharmacy HIT Collaborative | |||
| Draft USCDI V6 | Data related to an individual’s insurance coverage for health care. |
Relationship to Subscriber |
Relationship of a patient to the primary insured person. |
Mark Roberts | Leavitt Partners | |||
| Draft USCDI V6 | Data related to an individual’s insurance coverage for health care. |
Coverage Status |
Presence or absence of healthcare insurance. |
Mark Roberts | Leavitt Partners | |||
| Draft USCDI V6 | Provider-authored request for the delivery of patient care services. Usage notes: Orders convey a provider’s intent to have a service performed on or for a patient, or to give instructions on future care. |
Provider-authored request for end-of-life or life-sustaining care for a person who has a serious life-limiting medical condition. Usage note: These are meant to follow a person regardless of when and where such an order might be needed (e.g., hospital, care facility, community, home). There are variations in requirements and names for portable medical orders based on jurisdiction. Examples include but are not limited to POLST (Portable Medical Order for Life-Sustaining Treatment), MOLST (Medical Orders for Life-Sustaining Treatment), and out-of-hospital DNR (do-not-resuscitate). |
Grace Glennon on behalf of Joel Andress and CMS-CCSQ | On behalf of Centers for Medicare and Medicaid Services (CMS) Center for Clinical Standards and Quality (CCSQ) | ||||
| Draft USCDI V6 | Data used to categorize individuals for identification, records matching, and other purposes. |
Tribal Affiliation |
Tribe or band with which an individual associates. |
Laura Conn | ||||
| Draft USCDI V6 | Analysis of clinical specimens to obtain information about the health of a patient. |
Categorical assessment of a laboratory value, often in relation to a test's reference range. Examples include but are not limited to high, low, critical high, and normal. |
|
Riki Merrick | Association of Public Health Laboratories | |||
| Draft USCDI V6 | Analysis of clinical specimens to obtain information about the health of a patient. |
Specimen Identifier |
Sequence of characters assigned by a laboratory for an individual specimen. Example includes but is not limited to accession number. |
Riki Merrick | Association of Public Health Laboratories | |||
| Draft USCDI V6 | Assessments of a health-related matter of interest, importance, or worry to a patient, patient’s family, or patient’s healthcare provider that could identify a need, problem, or condition. |
Alcohol Use |
Evaluation of a patient's consumption of alcohol. Examples include but are not limited to history of alcohol use, alcohol use disorder identification test, and alcohol intake assessment. |
|
Clem McDonald | National Library of Medicine | ||
| Draft USCDI V6 | Narrative patient data relevant to the context identified by note types.
|
Operative Note |
Narrative summary of a surgical procedure. Usage note: May include procedures performed, operative and anesthesia times, findings observed, fluids administered, specimens obtained, and complications identified. |
|
Leslie Kelly Hall | Engaging Patient Strategy | ||
| Draft USCDI V6 | Findings or other clinical data collected about a patient during care. |
Information about a patient or provider authored document indicating its location, content, type, and verification status. Usage note: May include structured or unstructured data, whether a person has one or more advance directive documents, the type of advance directive, the location of the document, and whether it has been verified. Such documents may be used should a person be unable to communicate their wishes, preferences, or priorities to their provider. Examples include but are not limited to an indication that a living will is on file, a reference to the location of durable medical power of attorney, and the validating provider. |
Rachel Eager | New York eHealth Collaborative | ||||
| Draft USCDI V6 | Information that guides treatment of the patient and recommendations for future treatment. |
Care Plan |
Shared plan informed by members of a coordinated care team that details conditions, needs, and goals along with strategies for addressing them. Usage notes: Includes prioritized problems, health concerns, assessments, goals, and interventions from across care settings. Examples include nursing care plan, diabetic care plan, multiple chronic conditions care plan, and long term services and support care plan. |
Julia Skapik | NACHC | |||
| Draft USCDI V6 | Analysis of clinical specimens to obtain information about the health of a patient. |
Information regarding a specimen, including the container, that does not meet a laboratory’s criteria for acceptability. Usage note: This may include information about the contents of the container, the container, and the label. Examples include but are not limited to hemolyzed, clotted, container leaking, and missing patient name. |
|
Han Tran | College of American Pathologists (CAP) | |||
| Draft USCDI V6 | Analysis of clinical specimens to obtain information about the health of a patient. |
Upper and lower limit of quantitative test values expected for a designated population of individuals. Usage note: Reference range values may differ by patient characteristics, laboratory test manufacturer, and laboratory test performer. |
|
Nedra Y Garrett | CDC | |||
| Draft USCDI V6 | Analysis of clinical specimens to obtain information about the health of a patient. |
Unit of measurement to report quantitative laboratory test results. |
|
Nedra Y Garrett | CDC | |||
| Draft USCDI V6 | Assessments of a health-related matter of interest, importance, or worry to a patient, patient’s family, or patient’s healthcare provider that could identify a need, problem, or condition. |
Evaluation of a patient's current or usual exercise. Examples include but are not limited to frequency of muscle-strengthening physical activity, days per week with moderate to strenuous physical activity, and minutes per day of moderate to strenuous physical activity. |
|
Laurie P. Whitsel | American Heart Association/Physical Activity Alliance | |||
| Draft USCDI V6 | Narrative patient data relevant to the context identified by note types.
|
Emergency Department Note |
Narrative summary of care delivered in an emergency department. |
|
Smitha Vellanky, on behalf of Joel Andress and Centers for Medicare and Medicaid Services (CMS) Center for Clinical Standards and Quality (CCSQ) | On behalf of Centers for Medicare and Medicaid Services (CMS) Center for Clinical Standards and Quality (CCSQ) | ||
| Draft USCDI V6 | Pharmacologic agents used in the diagnosis, cure, mitigation, treatment, or prevention of disease. |
Physiological administration path of a therapeutic agent into or onto a patient. Examples include but are not limited to oral, topical, and intravenous. |
|
Smitha Vellanky, on behalf of Joel Andress and Centers for Medicare and Medicaid Services (CMS) Center for Clinical Standards and Quality (CCSQ) | On behalf of Centers for Medicare and Medicaid Services (CMS) Center for Clinical Standards and Quality (CCSQ) |